Avalon Ventures Funds Antibiotics Development at New Startup, RQx Pharmaceuticals

Xconomy -- San Diego’s Avalon Ventures, which prefers to launch its own seed-stage startups, has provided $1 million in funding for RQx Pharmaceuticals, a new San Diego life sciences company founded earlier this year, according to a recent regulatory filing.
MORE ON THIS TOPIC